HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A M Lincoff Selected Research

Platelet Membrane Glycoproteins

2/2002Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker.
7/2001Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: prospective analysis from PURSUIT.
3/2001Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.
2/2001Platelet glycoprotein IIb/IIIa inhibitors combined with fibrinolytic agents to treat acute myocardial infarction.
2/2001Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators.
9/2000Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators.
9/2000Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition. Insights from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.
7/2000Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade.
6/2000Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators.
4/2000Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A M Lincoff Research Topics

Disease

25Myocardial Infarction
07/2006 - 01/2000
17Acute Coronary Syndrome
03/2005 - 02/2000
9Hemorrhage
07/2006 - 04/2000
9Unstable Angina
07/2002 - 02/2000
6Infarction (Infarctions)
07/2002 - 03/2000
3Ischemia
03/2005 - 01/2000
3ST Elevation Myocardial Infarction
01/2003 - 04/2000
3Diabetes Mellitus
08/2001 - 02/2000
3Cardiovascular Diseases (Cardiovascular Disease)
07/2001 - 03/2001
2Thrombocytopenia (Thrombopenia)
08/2001 - 07/2000
2Myocardial Ischemia (Ischemic Heart Diseases)
03/2001 - 10/2000
2Coronary Artery Disease (Coronary Atherosclerosis)
10/2000 - 04/2000
2Heart Failure
10/2000 - 06/2000
1Rheumatoid Arthritis
01/2018
1Arthritis (Polyarthritis)
01/2018
1Osteoarthritis
01/2018
1Heart Diseases (Heart Disease)
01/2003
1Non-ST Elevated Myocardial Infarction
07/2002
1Hyperplasia
08/2001
1Inflammation (Inflammations)
07/2001
1Hemorrhagic Stroke
07/2001
1Stroke (Strokes)
07/2001
1Coronary Disease (Coronary Heart Disease)
04/2001
1Left Ventricular Dysfunction
10/2000
1Chest Pain (Chest Pains)
09/2000
1Pathologic Constriction (Stenosis)
09/2000
1Insulin Resistance
03/2000
1Obesity
03/2000
1Hypertension (High Blood Pressure)
03/2000
1Coronary Thrombosis
02/2000

Drug/Important Bio-Agent (IBA)

15Abciximab (ReoPro)FDA Link
01/2003 - 02/2000
14Eptifibatide (Integrilin)FDA Link
07/2002 - 02/2000
12Platelet Membrane GlycoproteinsIBA
02/2002 - 02/2000
9Glycoproteins (Glycoprotein)IBA
10/2003 - 02/2000
8Heparin (Liquaemin)FDA LinkGeneric
03/2005 - 04/2000
5Platelet Membrane Glycoprotein IIbIBA
02/2001 - 02/2000
3Pharmaceutical PreparationsIBA
03/2005 - 02/2001
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
07/2001 - 04/2000
2(2S)- 2- (4- (((3S)- 1- acetimidoyl- 3- pyrrolidinyl)oxy)phenyl)- 3- (7- amidino- 2- naphtyl)propanoic acidIBA
03/2005 - 02/2004
2MB Form Creatine KinaseIBA
02/2004 - 09/2000
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
03/2000 - 02/2000
1Naproxen (Naprosyn)FDA LinkGeneric
01/2018
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2018
1Ibuprofen (Motrin)FDA LinkGeneric
01/2018
1Esomeprazole (Nexium)FDA Link
01/2018
1Celecoxib (Celebrex)FDA Link
01/2018
1Factor Xa InhibitorsIBA
03/2005
1Factor Xa (Coagulation Factor Xa)IBA
03/2005
1Creatine Kinase (Creatine Phosphokinase)IBA
02/2004
1Streptozocin (Streptozotocin)FDA Link
08/2001
1LigandsIBA
08/2001
1Immunoglobulins (Immunoglobulin)IBA
08/2001
1Phenobarbital (Luminal)FDA Link
08/2001
1P-SelectinIBA
08/2001
1GoldIBA
05/2001
1LipidsIBA
04/2001
1Ticlopidine (Ticlid)FDA LinkGeneric
03/2001
1Fibrinolytic Agents (Antithrombotic Agents)IBA
02/2001
1reteplaseFDA Link
11/2000
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
10/2000
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2000
1EnzymesIBA
06/2000
1AntithrombinsIBA
04/2000
1Tirofiban (Aggrastat)FDA Link
04/2000
1tranilastIBA
01/2000

Therapy/Procedure

18Percutaneous Coronary Intervention
07/2006 - 02/2000
15Therapeutics
10/2003 - 03/2000
1Retreatment
08/2001
1Platelet Transfusion (Blood Platelet Transfusions)
08/2001
1Drug Tapering
12/2000
1Operative Surgical Procedures
08/2000
1Stents
07/2000